Joilton Lutterbach’s Ultimate Fighting Championship tenure has ended before he was able to set foot into the Octagon.
On Tuesday, Combat Sports Anti-Doping (CSAD) announced that Lutterbach tested positive for a metabolite of the anabolic steroid drostanolone in an out-of-competition sample collected on June 8. That test occurred two weeks before Lutterbach was scheduled to face Sharabutdin Magomedov at UFC on ABC 6 in Saudi Arabia.
Lutterbach was notified of his positive test on June 20 at the fighter hotel in Saudi Arabia, where he admitted use of the banned substance. Because he did not declare the use of drostanolone before being tested, he received a two-year suspension from CSAD. Additionally, the UFC has terminated his contract with the promotion. Lutterbach will be eligible to return to active competition on June 23, 2026.
“I actually used juice [three] months ago and had no idea I would sign with the UFC,” Lutterbach wrote on Instagram on June 20. I could have hidden in the mountains or gone to Thailand to hide as many do and are not tested, but I preferred to take the risk and believe I was clean and fit to fight.”
The 31-year-old Brazilian owns a 38-9 professional record with one no contest. He has competed for organizations such as Brave Combat Federation, Professional Fighters League, Cage Warriors, KSW and M-1 Global, to name a few.
